Glass House Brands (GLAS) Share-based Compensation (2020 - 2026)

Glass House Brands' (GLAS) quarterly Share-based Compensation came in at $4.5 million in Q1 2026, up 114.87% year-on-year from $2.1 million in Q1 2025, and up 5.83% on a QoQ basis from $4.3 million in Q4 2025.

Glass House Brands (GLAS) Share-based Compensation (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 7 years of Share-based Compensation data on file, last reported at $4.5 million in Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 114.87% year-over-year to $4.5 million in Q1 2026; TTM through Mar 2026 was $15.8 million, a 32.6% increase from a year earlier, with the FY2025 full-year figure at $13.4 million, up 2.32% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $4.5 million, up from $4.3 million in the prior quarter.
  • Over the last five years, Share-based Compensation for GLAS reached as high as $4.5 million in Q1 2026 and fell as low as $1.5 million in Q2 2023.
  • Historically, Share-based Compensation has averaged $3.0 million across 5 years, with a median of $2.9 million in 2024.
  • Across the five-year window, Share-based Compensation soared 323.63% in 2022 and plunged 56.12% in 2023, its largest moves.
  • Year by year, Share-based Compensation stood at $3.8 million in 2022, then plunged by 49.36% to $1.9 million in 2023, then surged by 70.66% to $3.3 million in 2024, then jumped by 31.18% to $4.3 million in 2025, then gained by 5.83% to $4.5 million in 2026.
  • Per Business Quant data, the three most recent Share-based Compensation figures were $4.5 million in Q1 2026, $4.3 million in Q4 2025, and $4.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 43.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 25.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 125.69 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 58.30 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 56.50 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 55.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 21.00 Mn
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn 4.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.52 Mn
Mar 31, 2026 4.52 Mn
Dec 31, 2025 4.27 Mn
Dec 31, 2025 4.27 Mn
Sep 30, 2025 4.08 Mn
Sep 30, 2025 4.08 Mn
Jun 30, 2025 2.94 Mn
Jun 30, 2025 2.94 Mn
Mar 31, 2025 2.11 Mn
Mar 31, 2025 2.11 Mn
Dec 31, 2024 3.26 Mn
Dec 31, 2024 3.26 Mn
Sep 30, 2024 2.95 Mn
Sep 30, 2024 2.95 Mn
Jun 30, 2024 3.62 Mn
Jun 30, 2024 3.62 Mn
Mar 31, 2024 3.27 Mn
Mar 31, 2024 3.27 Mn
Dec 31, 2023 1.91 Mn
Dec 31, 2023 1.91 Mn